Monte Rosa Therapeutics Inc (NASDAQ:GLUE)’s traded shares stood at 1.38 million during the last session, with the company’s beta value hitting 1.50. At the close
Monte Rosa Therapeutics Inc (NASDAQ:GLUE) has a beta value of 1.47 and has seen 2.5 million shares traded in the last trading session. The company,
During the last session, Monte Rosa Therapeutics Inc (NASDAQ:GLUE)’s traded shares were 0.6 million, with the beta value of the company hitting 1.47. At the
Monte Rosa Therapeutics Inc (NASDAQ:GLUE)’s traded shares stood at 0.83 million during the last session, with the company’s beta value hitting 1.40. At the close
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
